{"id":150857,"date":"2023-08-02T08:03:59","date_gmt":"2023-08-02T12:03:59","guid":{"rendered":"https:\/\/44.250.171.167\/?p=150857"},"modified":"2023-08-02T08:04:01","modified_gmt":"2023-08-02T12:04:01","slug":"lyka-labs-ltd-q1fy24-17-fall-in-revenue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/lyka-labs-ltd-q1fy24-17-fall-in-revenue\/","title":{"rendered":"Lyka Labs Ltd Q1FY24; 17% fall in Revenue"},"content":{"rendered":"\n<p>Lyka labs Ltd is a pharmaceutical company engaged in development, manufacturing and marketing of pharmaceutical products. It has a well-diversified business model in terms of markets, therapies and products.<br>It is one of the oldest company in the Indian Pharmaceutical Industry having presence in Domestic and International markets.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Lyka Labs Ltd reported Revenues for Q1FY24 of \u20b922.88 Crores down from \u20b927.49 Crore year on year, a fall of 16.77%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY24 of \u20b925.06 Crores down from \u20b927.68 Crores year on year, a fall of 9.47%.<\/p>\n\n\n\n<p>Consolidated Net Profit of -\u20b91.85 Crores from \u20b90.60 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is -\u20b90.56, from \u20b90.21 in the same quarter of the previous year.<\/p>\n\n\n\n<div class=\"wp-block-image is-style-default\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65-839x1024.png\" alt=\"\" class=\"wp-image-150859\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-65.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lyka labs Ltd is a pharmaceutical company engaged in development, manufacturing and marketing of pharmaceutical products. It has a well-diversified business model in terms of markets, therapies and products.It is one of the oldest company in the Indian Pharmaceutical Industry having presence in Domestic and International markets. Financial Results: Lyka Labs Ltd reported Revenues for [&hellip;]<\/p>\n","protected":false},"author":1885,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[10162],"class_list":["post-150857","post","type-post","status-publish","format-standard","hentry","category-infographics","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":150251,"url":"https:\/\/alphastreet.com\/india\/laurus-labs-ltd-q1fy24-94-fall-in-profits\/","url_meta":{"origin":150857,"position":0},"title":"Laurus Labs Ltd Q1FY24; 94% fall in Profits","author":"Karan_Singh","date":"July 27, 2023","format":false,"excerpt":"Laurus Labs is principally engaged in offering a broad and integrated portfolio of Active Pharmaceuticals Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Financial Results: Laurus Labs Ltd reported Revenues for Q1FY24 of \u20b91,108.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-325.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-325.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-325.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-325.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-325.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/07\/image-325.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":153880,"url":"https:\/\/alphastreet.com\/india\/venus-remedies-ltd-q1fy24-83-fall-in-profits\/","url_meta":{"origin":150857,"position":1},"title":"Venus Remedies Ltd Q1FY24; 83% fall in Profits","author":"Chirag Gupta","date":"August 14, 2023","format":false,"excerpt":"Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical products manufacturing. Financial Results: Venus Remedies Ltd reported Revenues for Q1FY24 of \u20b995.15 Crores down from \u20b9143.08 Crore year on year, a fall of 33.5%.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1064.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152269,"url":"https:\/\/alphastreet.com\/india\/kopran-ltd-q1fy24-64-fall-in-profits\/","url_meta":{"origin":150857,"position":2},"title":"Kopran Ltd Q1FY24; 64% fall in Profits","author":"Hardik Bhandare","date":"August 10, 2023","format":false,"excerpt":"Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide. Financial Results: Kopran Ltd reported Revenues for Q1FY24 of \u20b9117.00 Crores down from \u20b9125.62 Crore year on year, a fall of 6.86%. Total Expenses for Q1FY24 of \u20b9115.78 Crores down\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-533.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150942,"url":"https:\/\/alphastreet.com\/india\/jagsonpal-pharmaceuticals-ltd-q1fy24-156-rise-in-profits\/","url_meta":{"origin":150857,"position":3},"title":"Jagsonpal Pharmaceuticals Ltd Q1FY24; 156% rise in Profits","author":"Hardik Bhandare","date":"August 2, 2023","format":false,"excerpt":"Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets. Financial Results: Jagsonpal Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b960.15 Crores down from \u20b960.60 Crore year on year, a fall\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-93.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":150851,"url":"https:\/\/alphastreet.com\/india\/strides-pharma-science-ltd-q1fy24-1-fall-in-revenue\/","url_meta":{"origin":150857,"position":4},"title":"Strides Pharma Science Ltd Q1FY24; 1% fall in Revenue","author":"Chirag Gupta","date":"August 2, 2023","format":false,"excerpt":"Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in over 100 countries. The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-63.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-63.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-63.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-63.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-63.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-63.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164686,"url":"https:\/\/alphastreet.com\/india\/strides-pharma-science-ltd-q1fy24-1-fall-in-revenue-2\/","url_meta":{"origin":150857,"position":5},"title":"Strides Pharma Science Ltd Q1FY24; 1% fall in Revenue","author":"Chirag Gupta","date":"October 3, 2024","format":false,"excerpt":"Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in over 100 countries. The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-24.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-24.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-24.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-24.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-24.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-24.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/150857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=150857"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/150857\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=150857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=150857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=150857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}